Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 73
Filtrar
2.
Trends Mol Med ; 27(3): 231-247, 2021 03.
Artigo em Inglês | MEDLINE | ID: mdl-33218944

RESUMO

There is increasing evidence that extracellular vesicles (EVs) mediate the paracrine effects of stem cells. Although EVs have several attractive characteristics, they also raise issues related to delivery. For patients with cardiac disease that require a surgical procedure, direct intramyocardial (IM) administration of EVs is straightforward but its efficacy may be limited by fast wash-out, hence the interest of incorporating EVs into a controlled release polymer to optimize their residence time. For patients without surgical indication, the intravenous (IV) route is attractive because of its lack of invasiveness; however, whole-body distribution limits the fraction of EVs that reach the heart, hence the likely benefits of EV engineering to increase EV homing to the target tissue.


Assuntos
Materiais Biocompatíveis , Anormalidades Cardiovasculares/terapia , Sistemas de Liberação de Medicamentos/métodos , Vesículas Extracelulares , Bioengenharia , Humanos , Células-Tronco Mesenquimais/metabolismo , Células-Tronco/metabolismo
3.
Tissue Cell ; 64: 101330, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32473704

RESUMO

BACKGROUND: Mesenchymal stem cells (MSCs) are multipotent, genomic stable, self-renewable, and culturally expandable adult stem cells. MSCs facilitate tissue development, maintenance and repair, and produce secretory factors that support engraftment and trophic functions, marking them an attractive option in cell therapy, regenerative medicine and tissue engineering. METHOD: In this review, we summarize the recent researches regarding the isolation and characterization of MSCs, therapeutic applications and advanced engineering techniques. We also discuss the advantages and limitations that remain to be overcome for MSCs based therapy. RESULTS: It has been demonstrated that MSCs are able to modulate endogenous tissue and immune cells. Preclinical studies and early phase clinical trials have shown their great potential for tissue engineering of bone, cartilage, marrow stroma, muscle, fat, and other connective tissues. CONCLUSIONS: MSC-based therapy show considerable promise to rebuild damaged or diseased tissues, which could be a promising therapeutic method for regeneration medicine.


Assuntos
Células-Tronco Mesenquimais , Medicina Regenerativa/métodos , Células-Tronco Adultas , Osso e Ossos/patologia , Anormalidades Cardiovasculares/terapia , Diferenciação Celular , Humanos , Inflamação/terapia , Transplante de Células-Tronco Mesenquimais , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/imunologia , Células-Tronco Mesenquimais/metabolismo , Engenharia Tecidual
4.
Pediatrics ; 145(2)2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31964759

RESUMO

This set of recommendations is designed to assist the pediatrician in caring for children with Williams syndrome (WS) who were diagnosed by using clinical features and with chromosome 7 microdeletion confirmed by fluorescence in situ hybridization, chromosome microarray, or multiplex ligation-dependent probe amplification. The recommendations in this report reflect review of the current literature, including previously peer-reviewed and published management suggestions for WS, as well as the consensus of physicians and psychologists with expertise in the care of individuals with WS. These general recommendations for the syndrome do not replace individualized medical assessment and treatment.


Assuntos
Síndrome de Williams/complicações , Adolescente , Adulto , Fatores Etários , Anormalidades Cardiovasculares/etiologia , Anormalidades Cardiovasculares/terapia , Criança , Pré-Escolar , Constipação Intestinal/etiologia , Constipação Intestinal/terapia , Assistência Odontológica para Crianças/métodos , Fácies , Feminino , Transtornos da Audição/etiologia , Humanos , Hipercalcemia/complicações , Hipercalcemia/diagnóstico , Hipercalcemia/terapia , Hipotireoidismo/etiologia , Lactente , Masculino , Doenças do Sistema Nervoso/diagnóstico , Doenças do Sistema Nervoso/etiologia , Doenças do Sistema Nervoso/terapia , Fotografação , Exame Físico , Comportamento Problema/psicologia , Transição para Assistência do Adulto , Sistema Urinário/anormalidades , Síndrome de Williams/genética , Síndrome de Williams/terapia , Adulto Jovem
5.
Semin Fetal Neonatal Med ; 24(6): 101030, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31563413

RESUMO

The transition from fetal to neonatal life is a dramatic and complex process involving extensive physiologic changes, which are most obvious at the time of birth. Individuals who care for newly born infants must monitor the progress of the transition and be prepared to intervene when necessary. In the majority of births, this transition occurs without a requirement for any significant assistance. If newborns require assistance, the majority of the time respiratory support is all that is required. In some instances, however, there are circulatory emergencies that need to be rapidly identified or there may be dire consequences including death in the delivery room. This chapter will review various pathologies that are circulatory emergencies, and discuss how to assess them. We will also review new technologies which may help providers better understand the circulatory status or hemodynamic changes in the delivery room including heart rate, cardiac output, cerebral oxygenation and echocardiography.


Assuntos
Anormalidades Cardiovasculares , Sistema Cardiovascular/fisiopatologia , Doenças do Recém-Nascido , Administração dos Cuidados ao Paciente/métodos , Anormalidades Cardiovasculares/diagnóstico , Anormalidades Cardiovasculares/etiologia , Anormalidades Cardiovasculares/fisiopatologia , Anormalidades Cardiovasculares/terapia , Emergências/classificação , Humanos , Recém-Nascido , Doenças do Recém-Nascido/fisiopatologia , Doenças do Recém-Nascido/terapia , Neonatologia/métodos , Ultrassonografia Pré-Natal/métodos
6.
Vet Clin North Am Equine Pract ; 35(1): 139-157, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30871834

RESUMO

Pericardial, myocardial, and great vessel diseases are relatively rare in horses. The clinical signs are often nonspecific and vague, or related to the underlying cause. Physical examination usually reveals tachycardia, fever, venous distension or jugular pulsation, a weak or bounding arterial pulse, ventral edema, and abnormal cardiac auscultation such as arrhythmia, murmur, or muffled heart sounds. The prognosis depends on the underlying cause and the disease progression, and ranges from full recovery to poor prognosis for survival. This article focuses on the etiology, diagnosis, prognosis, and treatment of pericarditis, pericardial mass lesions, myocarditis, cardiomyopathy, and great vessel aneurysm or rupture.


Assuntos
Anormalidades Cardiovasculares/veterinária , Cardiopatias/veterinária , Doenças dos Cavalos/diagnóstico , Animais , Aorta/anormalidades , Cardiomiopatias/diagnóstico , Cardiomiopatias/etiologia , Cardiomiopatias/terapia , Cardiomiopatias/veterinária , Anormalidades Cardiovasculares/diagnóstico , Anormalidades Cardiovasculares/etiologia , Anormalidades Cardiovasculares/terapia , Cardiopatias/diagnóstico , Cardiopatias/etiologia , Cardiopatias/terapia , Doenças dos Cavalos/etiologia , Doenças dos Cavalos/terapia , Cavalos , Miocardite/diagnóstico , Miocardite/etiologia , Miocardite/terapia , Miocardite/veterinária , Pericardite/diagnóstico , Pericardite/etiologia , Pericardite/terapia , Pericardite/veterinária , Prognóstico
7.
Biomed Res Int ; 2019: 3081029, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30809536

RESUMO

There is strong evidence that considerable health benefits can be achieved even with small amounts of physical activity. However, getting people to exercise regularly is a major challenge not least in the elderly population. This study investigated the feasibility and physiological health effects of a pragmatic 15-week exercise programme for sedentary elderly. In a single-blind randomised controlled trial, 45 sedentary 60-83-year-olds (25 women, 20 men) were randomly assigned (2:1 ratio) to a training group (TG, n=30) or a control group (CG, n=15). The training in TG consisted of a combination of exercise modalities (i.e., strength, aerobic fitness, stability, and flexibility training) performed once a week as supervised group-based training and a weekly home-based training for 15 weeks. Feasibility outcomes were exercise intensity, adherence, and adverse events. The primary outcome was change in aerobic fitness (VO2max/kg). Adherence was high (81%) for the supervised exercise and low (0%) for the home-based exercise. No acute injuries occurred in TG, but 4 subjects (13%) reported considerable joint pain related to training. Average heart rate (HR) during the supervised training was 104±12 beats/min (69.3±8.0%HRmax), with 3.9±7.3% of training time >90%HRmax. Intention-to-treat analyses revealed no between-group differences for aerobic fitness (P=0.790) or any secondary cardiovascular outcomes at 15-week follow-up (resting HR or blood pressure; P>0.05). Compared to CG, bodyweight (-2.3 kg, 95% CI -4.0 to -7.0; P=0.006), total fat mass (-2.0 kg, 95% CI -3.5 to -0.5; P=0.01), and total fat percentage (-1.6%, 95% CI -2.8 to -0.3; P=0.01) decreased in TG. The group-based supervised training had high adherence and moderate exercise intensity, whereas the home-based training was not feasible in this study population. This exercise programme performed once a week did not improve aerobic fitness. Thus, supervised training with more vigorous intensity control appears advisable. Clinical Study registration number is H-15016951.


Assuntos
Anormalidades Cardiovasculares/terapia , Terapia por Exercício , Comportamento Sedentário , Idoso , Idoso de 80 Anos ou mais , Pressão Sanguínea , Anormalidades Cardiovasculares/fisiopatologia , Anormalidades Cardiovasculares/prevenção & controle , Exercício Físico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Método Simples-Cego , Fatores de Tempo
8.
Vasc Endovascular Surg ; 53(2): 154-156, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30305009

RESUMO

We report a simple endovascular repair for symptomatic aberrant right subclavian artery (ARSA) in an 11-year-old girl. She had undergone tracheostomy due to hypoxic encephalopathy after cardiac surgery and suffered from dyspnea. Computed tomography revealed tracheal stenosis caused by a vascular ring made with an ARSA and the right common carotid artery. Transcatheter ARSA embolization using an Amplatzer vascular plug and coils was performed. Symptoms improved within a few days after this intervention and no complications such as upper extremity ischemia were encountered. Computed tomography showed the ARSA around the trachea had reduced in size and tracheal stenosis was improved.


Assuntos
Anormalidades Cardiovasculares/terapia , Embolização Terapêutica/métodos , Procedimentos Endovasculares/métodos , Artéria Subclávia/anormalidades , Estenose Traqueal/terapia , Traqueostomia/efeitos adversos , Anormalidades Cardiovasculares/complicações , Anormalidades Cardiovasculares/diagnóstico por imagem , Anormalidades Cardiovasculares/fisiopatologia , Criança , Angiografia por Tomografia Computadorizada , Dispneia/etiologia , Dispneia/terapia , Feminino , Humanos , Artéria Subclávia/diagnóstico por imagem , Artéria Subclávia/fisiopatologia , Estenose Traqueal/diagnóstico por imagem , Estenose Traqueal/etiologia , Estenose Traqueal/fisiopatologia , Resultado do Tratamento
11.
Mov Disord ; 33(3): 421-430, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29465787

RESUMO

BACKGROUND: The objective of this study was to investigate 24-month of effects of bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) on nonmotor symptoms in Parkinson's disease (PD). METHODS: In this prospective, observational, multicenter, international study including 67 PD patients undergoing bilateral STN-DBS, we examined the Non-motor Symptom Scale, Non-Motor Symptoms Questionnaire, Parkinson's Disease Questionnaire-8, Scales for Outcomes in Parkinson's Disease-motor examination, -activities of daily living, and -complications, and levodopa-equivalent daily dose preoperatively and at 5 and 24-month of follow-up. After checking distribution normality, longitudinal outcome changes were investigated with Friedman tests or repeated-measures analysis of variance and Bonferroni correction for multiple comparisons using multiple tests. Post hoc, Wilcoxon signed rank t tests were computed to compare visits. The strength of clinical responses was analyzed using effect size. Explorative Spearman correlations of change scores from baseline to 24-month follow-up were calculated for all outcomes. RESULTS: The Non-motor Symptom Scale and all other outcome parameters significantly improved from baseline to the 5-month follow-up. From 5 to 24-month, partial decrements in these gains were found. Nonetheless, comparing baseline with 24-month follow-up, significant improvements were observed for the Non-motor Symptom Scale (small effect), Scales for Outcomes in PD-motor examination showed a moderate effect, and Scales for Outcomes in Parkinson's Disease-complications and levodopa-equivalent daily dose showed large effects. Non-motor Symptom Scale change scores from baseline to 24-month follow-up correlated significantly with Parkinson's Disease Questionnaire-8, Scales for Outcomes in Parkinson's Disease-activities of daily living, and -motor complications change scores. CONCLUSIONS: This study provides evidence of beneficial effects of bilateral STN-DBS on nonmotor symptoms at 24-month follow-up. The extent of nonmotor symptom improvement was directly proportionate to improvements in quality of life, activities of daily living, and motor complications. This study underlines the importance of nonmotor symptoms for holistic assessments of DBS outcomes. © 2018 International Parkinson and Movement Disorder Society.


Assuntos
Estimulação Encefálica Profunda/métodos , Doença de Parkinson/complicações , Doença de Parkinson/terapia , Núcleo Subtalâmico/fisiologia , Resultado do Tratamento , Idoso , Antiparkinsonianos/uso terapêutico , Anormalidades Cardiovasculares/etiologia , Anormalidades Cardiovasculares/terapia , Feminino , Humanos , Cooperação Internacional , Levodopa/uso terapêutico , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/fisiopatologia , Doença de Parkinson/psicologia , Qualidade de Vida , Disfunções Sexuais Fisiológicas/etiologia , Disfunções Sexuais Fisiológicas/terapia , Transtornos do Sono-Vigília/etiologia , Transtornos do Sono-Vigília/terapia , Inquéritos e Questionários
13.
J Neurol ; 264(6): 1247-1253, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28550476

RESUMO

Obstructive sleep apnea (OSA) is a known-risk factor for cardiovascular diseases. There are indications that treatment with continuous positive airway pressure (CPAP) reduces the risk of new cardiovascular events. In this study, we analyzed the incidence of cardiovascular events in patients with OSA and compared for the impact of CPAP therapy. All polysomnographies performed in 2009 and 2010 were selected with an AHI ≥5 and patients older than 18 years. These 1110 patients were approached with a questionnaire about cardiovascular events and CPAP treatment. Finally, 554 patients were included in analyses. CPAP treatment was based on compliance (level 1 treatment) and extended with residual respiratory events (level 2 treatment). OSA was set as AHI ≥5 and classified in mild (AHI 5-15), moderate (AHI 15-30) and severe (AHI ≥30) OSA. 50 cardiovascular events occurred in 44 patients during follow-up (mean follow-up time 5.9 years) in 554 patients. The events were significantly higher in patients with increasing classification of OSA-severity (p = 0.016). A first-ever cardiovascular event did not differ significantly between mild, moderate and severe OSA. Untreated CPAP patients had significantly more cardiovascular events as compared to treated patients with a hazard ratio of 2.66 partially adjusted for age, AHI and smoking. There was no significant contribution of other cardiovascular risk factors. Patients with OSA with an indication for CPAP treatment have more cardiovascular events when untreated compared to treated patients. This indicates that treatment of OSA by CPAP can reduce the risk for cardiovascular events.


Assuntos
Anormalidades Cardiovasculares/complicações , Pressão Positiva Contínua nas Vias Aéreas/métodos , Apneia Obstrutiva do Sono/complicações , Apneia Obstrutiva do Sono/terapia , Acidente Vascular Cerebral/complicações , Adulto , Idoso , Anormalidades Cardiovasculares/epidemiologia , Anormalidades Cardiovasculares/terapia , Eletromiografia , Feminino , Humanos , Incidência , Estimativa de Kaplan-Meier , Masculino , Pessoa de Meia-Idade , Polissonografia , Apneia Obstrutiva do Sono/epidemiologia , Estatísticas não Paramétricas , Acidente Vascular Cerebral/epidemiologia , Inquéritos e Questionários
15.
Am J Med Genet A ; 170(10): 2617-31, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27302097

RESUMO

Myhre syndrome is a rare, distinctive syndrome due to specific gain-of-function mutations in SMAD4. The characteristic phenotype includes short stature, dysmorphic facial features, hearing loss, laryngotracheal anomalies, arthropathy, radiographic defects, intellectual disability, and a more recently appreciated spectrum of cardiovascular defects with a striking fibroproliferative response to surgical intervention. We report four newly described patients with typical features of Myhre syndrome who had (i) a mildly narrow descending aorta and restrictive cardiomyopathy; (ii) recurrent pericardial and pleural effusions; (iii) a large persistent ductus arteriosus with juxtaductal aortic coarctation; and (iv) restrictive pericardial disease requiring pericardiectomy. Additional information is provided about a fifth previously reported patient with fatal pericardial disease. A literature review of the cardiovascular features of Myhre syndrome was performed on 54 total patients, all with a SMAD4 mutation. Seventy percent had a cardiovascular abnormality including congenital heart defects (63%), pericardial disease (17%), restrictive cardiomyopathy (9%), and systemic hypertension (15%). Pericarditis and restrictive cardiomyopathy are associated with high mortality (three patients each among 10 deaths); one patient with restrictive cardiomyopathy also had epicarditis. Cardiomyopathy and pericardial abnormalities distinguish Myhre syndrome from other disorders caused by mutations in the TGF-ß signaling cascade (Marfan, Loeys-Dietz, or Shprintzen-Goldberg syndromes). We hypothesize that the expanded spectrum of cardiovascular abnormalities relates to the ability of the SMAD4 protein to integrate diverse signaling pathways, including canonical TGF-ß, BMP, and Activin signaling. The co-occurrence of congenital and acquired phenotypes demonstrates that the gene product of SMAD4 is required for both developmental and postnatal cardiovascular homeostasis. © 2016 Wiley Periodicals, Inc.


Assuntos
Anormalidades Cardiovasculares/diagnóstico , Anormalidades Cardiovasculares/genética , Criptorquidismo/diagnóstico , Criptorquidismo/genética , Transtornos do Crescimento/diagnóstico , Transtornos do Crescimento/genética , Deformidades Congênitas da Mão/diagnóstico , Deformidades Congênitas da Mão/genética , Deficiência Intelectual/diagnóstico , Deficiência Intelectual/genética , Mutação , Fenótipo , Proteína Smad4/genética , Adolescente , Adulto , Anormalidades Cardiovasculares/terapia , Criança , Criptorquidismo/terapia , Ecocardiografia , Éxons , Fácies , Feminino , Estudos de Associação Genética , Transtornos do Crescimento/terapia , Deformidades Congênitas da Mão/terapia , Sequenciamento de Nucleotídeos em Larga Escala , Humanos , Hibridização in Situ Fluorescente , Deficiência Intelectual/terapia , Imageamento por Ressonância Magnética , Masculino , Tomografia Computadorizada por Raios X , Resultado do Tratamento , Ultrassonografia , Adulto Jovem
16.
Vasc Endovascular Surg ; 50(6): 458-9, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27334477

RESUMO

Right-side aortic arch is a rare congenital aortic anomaly occurring in 0.05% to 0.1% of the general population. Approximately, half of these cases may be associated with an aberrant left subclavian artery and occasionally with aneurysmatic change at its origin known as Kommerell diverticulum or aneurysm (KA). Herein we report a challenging case of a right-side aortic arch associated with KA incidentally observed in a 73-year-old male with metastatic lung cancer. After careful multidisciplinary discussion, a conservative strategy of care was successfully adopted.


Assuntos
Aneurisma/terapia , Aorta Torácica/anormalidades , Anormalidades Cardiovasculares/terapia , Neoplasias do Colo/patologia , Transtornos de Deglutição/terapia , Neoplasias Pulmonares/secundário , Artéria Subclávia/anormalidades , Idoso , Aneurisma/complicações , Aneurisma/diagnóstico por imagem , Aorta Torácica/diagnóstico por imagem , Aortografia/métodos , Anormalidades Cardiovasculares/complicações , Anormalidades Cardiovasculares/diagnóstico por imagem , Angiografia por Tomografia Computadorizada , Transtornos de Deglutição/complicações , Transtornos de Deglutição/diagnóstico por imagem , Humanos , Achados Incidentais , Neoplasias Pulmonares/diagnóstico por imagem , Masculino , Artéria Subclávia/diagnóstico por imagem , Fatores de Tempo , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...